Epigenetics Diagnostics Market, By Product (Reagents, Kits, Instruments & Consumables, Bioinformatics Tools & Enzymes), By Technology (DNA Methylation, Histone Methylation, Chromatin Structures, Histone Acetylation, Large Non-Coding RNA & MicroRNA Modification), By Application (Oncology, Cardiovascular Diseases, Metabolic Diseases, Immunology, Inflammatory Diseases, Infectious Diseases & Others), By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) & Others), Distribution Channel (Direct Tender & Retail Sales) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI481721 | Publish Date: May 2023 | No. of Pages: 126

Global Epigenetics Diagnostics Market Overview

The study of genetics, cellular and physical characteristic changes, and developmental biology that are induced by the external environment is known as epigenetics diagnosis. This, in turn, has an effect on genes and the ability of cells to read genes without being influenced by genotype. The underlying DNA and RNA sequences remain unaltered, and epigenetic modifications result in changes in the phenotype of the organism rather than the genotype. Because epigenetic modifications are dynamic and change with the environment, they are critical for development. Epigenetics affects the genetic manifestations of organisms, making it the most important topic in molecular biology and developmental genetics. The National Center Institute, the National Institute of Health, and the International Human Epigenome Consortium are all sponsoring and supporting epigenetics research and development. Epigenetics is also utilised to treat a number of chronic disorders, including cancer, metabolic diseases, and autoimmune diseases. The Epigenetics Diagnostics Market accounted for US$ 4265.23 million in 2020 and is estimated to be US$ 12686.6 million by 2030 and is anticipated to register a CAGR of 11.5%.

Global Epigenetics Diagnostics Market Dynamics

Funds in Research and Development Projects will drive the growth of the Market

These organizations are expected to fund research and development projects in order to better understand epigenetic alterations at the molecular level and find therapeutic treatments. Furthermore, the NCI's Division of Cancer's Epidemiology and Genomics Research Program (EGRP) funds research projects based on innovative epigenetic research, which is a driving force in the industry. For instance, According to the National Institutes of Health, the number of cancer fatalities in the United States is expected to be 171.2 per 100,000 men and women per year. The high prevalence is due to the high incidence rate, death and survival data, information on cancer symptoms, risk factors, early detection, and early treatment. The International Cancer Genome Consortium (ICGC) is working to characterize the genomics, epigenomic alterations, and transcriptome changes in various tumor types.

Epigenetics players are partnering with one another to improve epigenetics application. This is projected to open up a number of attractive opportunities for the global epigenetics market to expand. Other key factors projected to boost growth in the worldwide epigenetic diagnostics market include rising cases of cancer and other chronic diseases around the world, as well as an increase in the geriatric population. Furthermore, increased commercial and public investment is supporting enhanced gene, cellular, and protein research, resulting in significant epigenetic reagent advances. Furthermore, epigenetic variables such as chromatin structure, non-coding RNAs, and DNA methylation can be used to influence gene expression. This is pushing epigenetics acceptance in the life sciences and analytical tools markets, resulting in increased demand for epigenetics globally. Finally, rising FDA approval of several epigenetics diagnostics medications and equipment is likely to boost the market forward.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Epigenetics Diagnostics Market Segmentation

 

                                                           Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global Epigenetics Diagnostics Market is segmented based on product, technology, application, end-user, distribution channel and region.

On the basis of Product, the Global Epigenetics Diagnostics Market is segmented into Reagents, Kits, Instruments & Consumables, and Bioinformatics Tools & Enzymes. Based on Technology, the target market is segmented into DNA Methylation, Histone Methylation, Chromatin Structures, Histone Acetylation, and Large Non-Coding RNA & MicroRNA Modification. Based on Application, the target market is segmented into Oncology, Cardiovascular Diseases, Metabolic Diseases, Immunology, Inflammatory Diseases, and Infectious Diseases & Others. Based on End-User, the target market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) & others. Based on Distribution Channel, the target market is segmented into Direct Tender & Retail Sales.

 

Regional Insights:

 

                                                                                                                                                                    Source: Prophecy Market Insights

                                                             

 

On region the Global Epigenetics Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America surpassed Europe as the most important regional market. The presence of advanced technological facilities, successful initiatives, the constantly growing ageing population, enhanced healthcare facilities, government financing for ongoing epigenetic research activities, attentive research, and precise diagnostic techniques are all major market drivers. Furthermore, the Common Fund-funded projects in the United States are expected to expand epigenetic research activities across a wide variety of disorders, including oncology and non-oncology diseases like cardiovascular, metabolic, and inflammatory diseases. Due to increased disposable income, significant unmet clinical requirements of patients, rising knowledge of early diagnosis, and availability of efficient treatment in emerging nations such as India and China, Asia Pacific is expected to grow at the quickest rate over the projection period. Due to an increase in cancer cases, Asia Pacific is in the spotlight.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Product- Reagents, Kits, Instruments & Consumables, Bioinformatics Tools & Enzymes

By Technology– DNA Methylation, Histone Methylation, Chromatin Structures, Histone Acetylation, Large Non-Coding RNA & MicroRNA Modification

By Application- Oncology, Cardiovascular Diseases, Metabolic Diseases, Immunology, Inflammatory Diseases, Infectious Diseases & Others

By End-User- Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) & Other

By Distribution Channel- Direct Tender & Retail Sales

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Epigenetics Diagnostics Market report based on product, technology, application, end-user, distribution channel and region.

Global Epigenetics Diagnostics Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Epigenetics Diagnostics Market Key Players

The key players operating in the epigenetics diagnostic market are Zymo Research Corporation, PerkinElmer Inc., Diagenode, a Hologic company, F. Hoffman-La Roche Ltd, EPICYPHER, Cambridge Epigenetix (CEGX), Promega Corporation, QIAGEN, Pacific Biosciences of California, Inc., Epigenomics AG, Mnemo, Reaction Biology, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Merck KGaA, Illumina, Inc., ACTIVEMOTIF, New England Biolabs, Thermo Fisher Scientific, Inc., EpiGentek Group Inc., Enzo Life Sciences, Inc., Epizyme, Inc., GlaxoSmithKline plc., Eclipse BioInnovations, MDxHealth, Abcam plc., Salarius Pharmaceuticals, Inc., Datar Cancer Genetics, and Bluestar Genomics Inc. among others.

Global Epigenetics Diagnostics Market Company Profile

  • Zymo Research Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PerkinElmer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Diagenode
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Hologic company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffman-La Roche Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cisco Systems
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • EPICYPHER
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cambridge Epigenetix (CEGX)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Epigenetics Diagnostics Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Epigenetics Diagnostic Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End-User
      • Market Snippet, By Distribution Channel
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Epigenetics Diagnostics Market, By Product, 2020 – 2030, (US$ Mn)
    • Overview                                       
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Reagents
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Kits
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Instruments & Consumables
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Bioinformatics Tool & Enzymes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Epigenetics Diagnostics Market, By Technology, 2020 – 2030, (US$ Mn)
    • Overview                                                        
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • DNA Methylation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Histone Methylation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Chromatin Structures
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Histone Acetylation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Large Non-Coding RNA & MicroRNA Modification
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Epigenetics Diagnostics Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview                                             
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Metabolic Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Immunology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Inflammatory Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Infectious Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Epigenetics Diagnostics Market, By End-User, 2020 – 2030, (US$ Mn)
    • Overview                                                  
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Academic and Research Institutes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmaceutical and Biotechnology Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Contract Research Organizations (CROs)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Epigenetics Diagnostics Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
    • Overview                                                  
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Direct Tender
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Retail Sale
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
      •  
  10. Global Epigenetics Diagnostics Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  11. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  12. Company Profiles
  • Zymo Research Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PerkinElmer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Diagenode
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Hologic company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffman-La Roche Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cisco Systems
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • EPICYPHER
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cambridge Epigenetix (CEGX)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Epigenetics Diagnostics Market is segmented based on product, technology, application, end-user, distribution channel and region.

Funds in Research and Development Projects is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the epigenetics diagnostic market are Zymo Research Corporation, PerkinElmer Inc., Diagenode, a Hologic company, F. Hoffman-La Roche Ltd, EPICYPHER, Cambridge Epigenetix (CEGX), Promega Corporation, QIAGEN, Pacific Biosciences of California, Inc., Epigenomics AG, Mnemo, Reaction Biology, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Merck KGaA, Illumina, Inc., ACTIVEMOTIF, New England Biolabs, Thermo Fisher Scientific, Inc., EpiGentek Group Inc., Enzo Life Sciences, Inc., Epizyme, Inc., GlaxoSmithKline plc., Eclipse BioInnovations, MDxHealth, Abcam plc., Salarius Pharmaceuticals, Inc., Datar Cancer Genetics, and Bluestar Genomics Inc. among others.